KALBE FARMA (Germany) Today
| LCLA Stock | EUR 0.06 0.00 0.00% |
PerformanceVery Weak
| Odds Of DistressLow
|
KALBE FARMA is selling for under 0.064 as of the 26th of February 2025; that is No Change since the beginning of the trading day. The stock's last reported lowest price was 0.064. KALBE FARMA has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 27th of January 2025 and ending today, the 26th of February 2025. Click here to learn more.
Moving against KALBE Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
KALBE Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. KALBE FARMA's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding KALBE FARMA or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President | Vidjongtius |
| Business Concentration | Other, Other (View all Sectors) |
KALBE FARMA (LCLA) is traded on Munich Exchange in Germany and employs 14 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.61 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate KALBE FARMA's market, we take the total number of its shares issued and multiply it by KALBE FARMA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. KALBE FARMA operates under Other sector and is part of Other industry.
Check KALBE FARMA Probability Of Bankruptcy
KALBE FARMA Risk Profiles
Although KALBE FARMA's alpha and beta are two of the key measurements used to evaluate KALBE FARMA's performance over the market, the standard measures of volatility play an important role as well.
KALBE Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in KALBE FARMA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Correlation Analysis Now
Correlation AnalysisReduce portfolio risk simply by holding instruments which are not perfectly correlated |
| All Next | Launch Module |
KALBE FARMA Corporate Directors
| Djonny Tjahyadi | Director | Profile | |
| Ongkie Tedjasurja | Director | Profile | |
| Sie Djohan | Director | Profile | |
| Bernadus Winata | Independent Director, Corporate Secretary | Profile |
Additional Tools for KALBE Stock Analysis
When running KALBE FARMA's price analysis, check to measure KALBE FARMA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy KALBE FARMA is operating at the current time. Most of KALBE FARMA's value examination focuses on studying past and present price action to predict the probability of KALBE FARMA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move KALBE FARMA's price. Additionally, you may evaluate how the addition of KALBE FARMA to your portfolios can decrease your overall portfolio volatility.